secwatch.observer — SEC 8-K summary
======================================

Issuer:     PRECISION BIOSCIENCES INC (DTIL)
CIK:        0001357874
Form:       8-K
Filed at:   2024-01-23T23:59:59+00:00
Accession:  0000950170-24-006661
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Precision BioSciences enters new exec employment agreements with enhanced severance
--------------------------------------------------------------------------------

- CEO Michael Amoroso: 18-month salary severance, 1.5x target bonus, 25-month equity acceleration.
- CFO Alex Kelly, GC Dario Scimeca, CRO Jeff Smith: 12-month salary severance, 1x target bonus, 13-month equity acceleration.
- Enhanced COBRA premium reimbursement and extended option exercise periods for all four executives.
- Agreements effective Jan 22, 2024, supersede prior employment agreements from September 2021.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1357874/000095017024006661/0000950170-24-006661-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1357874/000095017024006661/dtil-20240122.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-006661

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer